Approaches for the Evaluation of the National Cancer Institute's Summer Curriculum in Cancer Prevention: Lessons from the All-Ireland NCI Cancer Consortium

被引:2
|
作者
Otero, Isabel V. [1 ]
Williams, Makeda [1 ]
Harford, Joe B. [1 ]
机构
[1] NCI, Ctr Global Hlth, Off Director, Bethesda, MD 20892 USA
关键词
Cancer prevention; Molecular biology; Ireland; Northern Ireland; Capacity-building; Evaluation; FELLOWSHIP PROGRAM; WEIGHT;
D O I
10.1007/s13187-012-0368-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NCI Summer Curriculum in Cancer Prevention (SCCP) has provided interdisciplinary training in cancer prevention and control to cancer health-care professionals, including nurses, physicians, and scientists, since 1986. It has trained over 1,200 participants, 256 of them from Ireland and Northern Ireland through two summer courses: a 4-week course on Principles and Practice of Cancer Prevention and Control (PP) and 1-week on Molecular Prevention (MP). This report is our attempt to measure achievements and level of satisfaction among alumni from the island of Ireland upon return to their home institution. A questionnaire was developed to assess this. Our analysis found statistically significant differences in the types of accomplishments reported among respondents of the MP and PP courses as well as statistically significant differences in their level of satisfaction. More data are needed to better explain the differences observed as well as level of resources available to alumni upon their return home.
引用
收藏
页码:450 / 455
页数:6
相关论文
共 50 条
  • [11] Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)
    Wirth, Megan
    Blumberg, Dikla
    Mosby-Griffin, Kimberly
    Vena, Don
    [J]. TRIALS, 2017, 18
  • [12] Introducing the US National Cancer Institute's Small Cell Lung Cancer Consortium
    Ujhazy, Peter
    Szabo, Eva
    Forry, Suzanne
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S730 - S730
  • [13] Evaluation of Radioactivity in Patient Specimens Received in the Core Laboratory at a National Cancer Institute (NCI) Designated Cancer Center
    Suciu, Christopher G.
    Amurao, Max
    Luechtefeld, David
    Marko, Areti
    Ashby, Lori
    Gronowski, Ann M.
    [J]. CLINICAL CHEMISTRY, 2021, 67 (10) : 1415 - 1425
  • [14] Trends in the National Cancer Institute (NCI) Sponsored Lung Cancer Clinical Trials Pre and Post NCI's National Clinical Trials Network (NCTN)
    Malik, S.
    Mishkin, G.
    Denicoff, A.
    Zhao, J.
    Korn, E.
    Mooney, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S359 - S360
  • [15] Delivering prostate cancer prevention messages to the public: how the National Cancer Institute (NCI) effectively spread the word about the Prostate Cancer Prevention Trial (PCPT) results
    Croker, KS
    Ryan, A
    Morzenti, T
    Cave, L
    Maze-Gallman, T
    Ford, L
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) : 369 - 376
  • [16] Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela Jo
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, Jack
    Takebe, Naoko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [17] National Cancer Institute's Chemical Biology Consortium: An academic/public partnership for the discovery of novel cancer therapeutics
    Doroshow, James H.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [18] DISTRIBUTION OF MATERIALS FROM THE NATURAL-PRODUCTS REPOSITORY OF THE NATIONAL CANCER INSTITUTE (NCI)
    CRAGG, GM
    [J]. JOURNAL OF NATURAL PRODUCTS, 1992, 55 (02): : 265 - 265
  • [19] The Effect on Drug Development of the National Cancer Institute's Cancer Therapy Evaluation Program
    Zwiebel, James
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 157 - 159
  • [20] Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis
    Haji, Naemah
    Faizi, Masoma
    Koutentis, Panayiotis A. A.
    Carty, Michael P. P.
    Aldabbagh, Fawaz
    [J]. MOLECULES, 2023, 28 (13):